Finland· FI-REL-REL184
Norflex
A orphenadrine (citrate) product containing orphenadrine citrate, registered in Finland by Viatris Oy. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Orphenadrine (citrate) is registered in 2 of 19 countries.
Countries holding a registration under ATC M03BC01 (orphenadrine (citrate)), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Orphenadrine (citrate) · ATC M03BC01
2 / 19 countries
- Canada
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Orphenadrine citrate
- Manufacturer
- Viatris Oy
- Country
- Finland (FI)
- ATC code
- M03BC01
- ATC class
- Orphenadrine (citrate)
- Defined daily dose
- 0.12 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
145 interactions on record for orphenadrine (citrate).
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Orphenadrine (citrate) · interactions on record
145 records
- 7 severe
- 87 moderate
- 1 minor
- 50 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- MorphineN02AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Orphenadrine (citrate) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOrphenadrine CitrateLake Erie Medical DBA Quality Care Products LLC
- CanadaSANDOZ ORPHENADRINESANDOZ CANADA INCORPORATED
- SwedenNorflex 100 mg DepottablettViatris AB
- United KingdomBiorphen 25mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- NorwayDisipalAstellas Pharma AS
- GermanyNorflexViatris Healthcare Gmbh
- ItalyDISIPAL*50 cpr rivestite 50 mgECUPHARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Norflex, Norflex N
- Denmark · Lysantin
- United Kingdom (Northern Ireland) · Orphenadrine Hydrochloride Rosemont Pharmaceuticals
- Greece · Orphedrin
- Italy · Disipal
- Sweden · Norflex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/beefd1af-f947-4ff5-9f4a-2a6e85d14f73 GET /v1/drugs/beefd1af-f947-4ff5-9f4a-2a6e85d14f73?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.12",
"form": "depottabletti",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "100 mg",
"atc_label": "orfenadriini",
"ma_number": "1495",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL184",
"authorised_at": "1965-05-26"
}See everything about orphenadrine (citrate).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.